In the Spotlight
Read "Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer," the latest First Disclosure from Molecular Cancer Therapeutics. Learn more about the new First Disclosures article type and how to submit yours.
In the November issue of Cancer Immunology Research, read an update on the field of cancer immunology and the Journal in "Building on Success", the latest editorial from Editors-in-Chief Robert D. Schreiber and Philip D. Greenberg.
Clearing the Haze: What Do We Still Need to Learn About Electronic Nicotine Delivery Systems? Read the commentary in Cancer Prevention Research.
Read highlights from Blood Cancer Discovery, the latest journal from the AACR. This collection features recently published advances in hematologic malignancies selected from the first two journal issues by the Editors.
Visit the COVID-19 & Cancer Resource Center to access all content related to COVID-19 that is now freely available from across the AACR Journals.
Keep up with “what’s new” by following the AACR Journals on Twitter:
@BCD_AACR: Blood Cancer Discovery
@CD_AACR: Cancer Discovery
@CEBP_AACR: Cancer Epidemiology, Biomarkers & Prevention
@CIR_AACR: Cancer Immunology Research
@CAPR_AACR: Cancer Prevention Research
@CR_AACR: Cancer Research
@CCR_AACR: Clinical Cancer Research
@MCR_AACR: Molecular Cancer Research
@MCT_AACR: Molecular Cancer Therapeutics
